Testing effectiveness (Phase 2)Ended earlyNCT00113919
What this trial is testing
UARK 2003-25: A Study of Intravenous (IV) Busulfan (Busulfex®) in Multiple Myeloma Patients
Who this might be right for
Multiple Myeloma
University of Arkansas 14
Showing 3 of 0 results